D Projects Unblocked

DUBLIN—The European Commission is expected to agree later this fall to divert at least $462 million over the next five years from the EEC’s Regional Fund into helping the science infrastructure of its less favored regions. The proposal is based on work done for the EEC by Ireland’s science agency, the National Board for Science and Technology. The NBST was hired in 1985 to determine how Regional Fund monies— traditionally used for road, sewer and drainage projects&#

Written byDick Ahlstrom
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

DUBLIN—The European Commission is expected to agree later this fall to divert at least $462 million over the next five years from the EEC’s Regional Fund into helping the science infrastructure of its less favored regions.

The proposal is based on work done for the EEC by Ireland’s science agency, the National Board for Science and Technology. The NBST was hired in 1985 to determine how Regional Fund monies— traditionally used for road, sewer and drainage projects—could instead be used to boost the technological base of such countries as Ireland, Spain, Portugal, Greece and parts of Italy.

The EEC received the NBST’s final submission only last month, but its findings have already been built into a new program called STRIDE (Science and Technology for Research, Innovation and Development in Europe). Although details have yet to be released, STRIDE is expected to hew more closely than have past Regional Fund programs ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies